Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity-Reference-Cited by-同舟云学术

Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity

Published:2010-07-28 Issue:1 Volume:10 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Gunn Shelly,Yeh I-Tien,Lytvak Irina,Tirtorahardjo Budi,Dzidic Natasha,Zadeh Soheila,Kim Jaeweon,McCaskill Chris,Lim Lony,Gorre Mercedes,Mohammed Mansoor

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-10-396.pdf

Reference19 articles.

1. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor 2 testing in breast cancer. J Clin Oncol. 2007, 25: 118-145. 10.1200/JCO.2006.09.2775.

2. Tuma RS: Inconsistency of HER2 test raises questions. J Natl Cancer Inst. 2007, 99: 1064-1065. 10.1093/jnci/djm075.

3. Dowsett M, Hanna WM, Kockx M, Penault-Liorca F, Gutjhar T, Habben K, vand Vivjer MJ: Standardization of HER2 testing: results of an international proficiency-testing ring study. Modern Pathol. 2007, 20: 584-591. 10.1038/modpathol.3800774.

4. Yeh IT, Martin MA, Robetorye RS, Bolla AR, McCaskill C, Shah R, Gorre ME, Mohammed MS, Gunn SR: Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. Modern Pathol. 2009, 22: 1169-1175. 10.1038/modpathol.2009.78.

5. Marchio C, Lambros MB, Gugliotta P, Di Cantogno LVD, Botta C, Pasini B, Tan DSP, Mackay A, Fenwick K, Tamber N, Bussolati G, Asworth A, Reis-Fiho JS, Sapino A: Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis. J Pathol. 2009, 219: 16-24. 10.1002/path.2574.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status;The Breast Journal;2023-11-30

2. HER2-low breast cancer: Novel detections and treatment advances;Critical Reviews in Oncology/Hematology;2023-01

3. HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry;Cancer Cell International;2022-11-15

4. Predictive Biomarkers in Breast Cancer: ER, PR, and HER-2/NEU;Handbook of Practical Immunohistochemistry;2022

5. Impact of chromosome 17 centromere copy number increase on patient survival and human epidermal growth factor receptor 2 expression in gastric adenocarcinoma;Oncology Letters;2020-12-21